Privia Health Reports Strong Results in the 2025 Performance Year of the Medicare Shared Savings Program
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Privia Health Group (Nasdaq: PRVA) reported $374.0 million in Medicare shared savings across its accountable care organizations for the 2025 performance year. Savings rose 59.7% from 2024, or 38.1% excluding the Evolent Care Partners organization acquired in December 2025. The savings are shared among Medicare’s administering agency, Privia’s organizations and participating providers.
Based on the results, Privia raised its full-year 2026 outlook to $2,550–$2,600 million in GAAP revenue and $174–$177 million in adjusted EBITDA, from $2,500–$2,550 million and $154–$157 million, respectively. Guidance for implemented providers and attributed lives was unchanged. Privia now expects at least $550 million in year-end cash and cash equivalents, including the American Choice Healthcare outlay and assuming the 2025 Medicare savings settlement and related provider payments occur before year-end.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Major point. Forward-looking: it has not happened yet and may not happen.2026 adjusted EBITDA guidance rose to $174–$177 million from $154–$157 million, implying approximately 39.8% growth from 2025 at the midpoint
- Moderate point2025 Medicare shared savings rose 59.7% to $374.0 million across ten organizations, or 38.1% excluding the acquired Evolent Care Partners organization
- Moderate point. Forward-looking: it has not happened yet and may not happen.Year-end cash and cash equivalents are expected to be at least $550 million, including the American Choice Healthcare outlay, if the 2025 Medicare savings settlement and related provider payments occur before year-end
- Minor point. Forward-looking: it has not happened yet and may not happen.2026 GAAP revenue guidance rose to $2,550–$2,600 million from $2,500–$2,550 million
- Minor point. Forward-looking: it has not happened yet and may not happen.2026 practice collections guidance rose to $3,950–$4,000 million from $3,900–$3,950 million
11 minor points
- Minor point. Forward-looking: it has not happened yet and may not happen.2026 care margin guidance rose to $565–$570 million from $535–$540 million
- Minor point. Forward-looking: it has not happened yet and may not happen.2026 platform contribution guidance rose to $305–$310 million from $280–$285 million
- Minor point. Forward-looking: it has not happened yet and may not happen.2026 EBITDA margin guidance rose to 30.9% of care margin at the midpoint from 28.9%
- Minor point2025 Medicare savings rate was 9.3% across ten organizations; excluding the acquired organization, it was 11.2%, up more than 20% from 2024
- Minor pointGross savings per beneficiary reached $1,258 in 2025, more than 82% above the $690 across all accountable care organizations
- Minor pointSpending per beneficiary was 8% below the median program organization and 22% below Medicare in 2025
- Minor pointInpatient discharges per 1,000 beneficiaries were 19% below the median program organization and 30% below national Medicare in 2025
- Minor pointEmergency department visits per 1,000 beneficiaries were 17% below the median program organization and 26% below national Medicare in 2025
- Minor pointPrimary care visits per 1,000 beneficiaries were 26% above the median program organization and 27% above national fee-for-service Medicare in 2025
- Minor pointAvoided inpatient stays may have exceeded 18,000 in 2025, based on Privia’s comparison with Medicare facility care rates
- Minor pointAvoided emergency department visits may have exceeded 13,000 in 2025, based on Privia’s comparison with Medicare facility care rates
Negative
- Minor point. Forward-looking: it has not happened yet and may not happen.Year-end cash outlook assumes the 2025 Medicare savings settlement and related provider payments occur before year-end, based on current accruals
Key Figures
- 2025 MSSP shared savings
- $374.0 million
- 2025 performance year
- Shared savings growth
- 59.7%
- Compared with 2024
- GAAP revenue guidance
- $2,550–$2,600 million
- Updated full-year 2026 guidance
- Practice Collections guidance
- $3,950–$4,000 million
- Updated full-year 2026 guidance
- Care Margin guidance
- $565–$570 million
- Updated full-year 2026 guidance
- Platform Contribution guidance
- $305–$310 million
- Updated full-year 2026 guidance
- Adjusted EBITDA guidance
- $174–$177 million
- Updated full-year 2026 guidance
- Cash and cash equivalents
- At least $550 million
- Expected at year-end 2026, subject to stated settlement assumptions
Historical Context
-
November results raised FY2026 guidance; this update raises those same-year ranges again.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
aco technical
gaap financial
fee-for-service medical
ebitda financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
Privia Health’s Ten ACOs Delivered
Company Increases Full-Year 2026 Financial Guidance a
ARLINGTON, Va., Nov. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that its Accountable Care Organizations (ACOs) achieved shared savings of
The ten ACOs (collectively, Privia Quality Network or PQN) managed over
“Our strong performance in the 2025 Medicare Shared Savings Program underscores the effectiveness of our physician-led approach and the value of our comprehensive partnerships with physicians across multiple payer arrangements,” stated Dr. Bartley Bryt, Chief Medical Officer. “By putting physicians in the driver's seat and equipping them with essential tools, talent, and technology, we help improve outcomes for over 297,000 Medicare beneficiaries while managing the total cost of care.
“Our approach extends beyond MSSP, supporting physician practices across their entire patient populations and payer arrangements,” Dr. Bryt further elaborated, “By empowering physicians with data-driven insights, operational support, and aligned incentives, we help advance the quadruple aim: better patient outcomes, improved patient experiences, lower healthcare costs, and a better experience for the clinicians delivering care in our communities.”
Privia achieved strong performance across all of its network of physician-led ACOs. This points to the effectiveness of Privia’s primary care-centric partnership model and deep clinician-patient relationships that delivered significant, measurable clinical improvements and utilization outcomes during the MSSP 2025 performance year. Key performance metrics included:
- Higher Primary Care Visits in Lower Cost Setting: Primary care visits per 1,000 beneficiaries were
26% higher than the median MSSP ACO and27% higher than national fee-for-service Medicare, highlighting Privia’s primary care-centric model providing access to patients in a lower cost setting that helps mitigate the need for higher cost care - Lowered Acute Hospitalizations: Inpatient hospital discharges per 1,000 beneficiaries were
19% lower than the median MSSP ACO and30% lower than national Medicare - Reduced Emergency Care: Emergency department visits per 1,000 beneficiaries were
17% lower than the median MSSP ACO and26% lower than national Medicare - Preventing High-Cost Hospital Events: The favorable differences in facility care rates between Privia ACOs and Medicare suggest Privia reduced unnecessary inpatient stays by more than 18,000 and emergency department visits by over 13,000
- Significant Savings: Beneficiary per capita expenditures were
8% lower than the median MSSP ACO and22% lower than Medicare - Increased Savings Rate: Privia generated an aggregate savings rate of
9.3% across its ten ACOs. Excluding the ACO acquisition noted above, Privia’s ACOs delivered an aggregate savings rate of11.2% , an increase of more than20% over performance year 2024 - Significantly Higher Gross Per Capita Savings: In aggregate, Privia’s ten ACOs significantly outperformed all ACOs with higher gross per capita savings. Privia’s ACOs delivered gross per capita savings of
$1,258 , more than82% better when compared with all ACOs’ gross per capita savings of$690 , according to CMS
Privia Quality Network supports physician practices and more than 1.67 million attributed lives in CMS Medicare programs, Medicare Advantage, Commercial, and Medicaid arrangements. Since 2014, PQN has delivered total shared savings of over
Financial Guidance Update a
Based on Privia's 2025 MSSP results, management increased its financial guidance for full-year 2026, with its guidance for Implemented Providers and Attributed Lives both unchanged. Updated full-year 2026 financial guidance is as follows:
| ($ in Millions) | Updated Guidance | Guidance at 11.5.26 |
| GAAP Revenue | ||
| Practice Collections | ||
| Care Margin | ||
| Platform Contribution | ||
| Adjusted EBITDA | ||
| EBITDA Margin (at midpoint) | ||
| (as a % of Care Margin) | ||
- Management has not reconciled forward-looking non-GAAP measures to their most directly comparable GAAP measures of gross margin, operating income and net income. This is because the Company cannot predict with reasonable certainty and without unreasonable efforts the ultimate outcome of certain GAAP components of such reconciliations due to market-related assumptions that are not within our control as well as certain legal or advisory costs, tax costs or other costs that may arise. For these reasons, management is unable to assess the probable significance of the unavailable information, which could materially impact the amount of the future directly comparable GAAP measures.
Privia’s updated 2026 guidance reflects Adjusted EBITDA growth of approximately
About Privia Health
Privia Health™ is one of the largest physician enablement companies in the United States with a presence in 25 states and the District of Columbia. Privia builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. Privia collaborates with medical groups, health plans and health systems to optimize ~1,400 physician practices, improve the patient experience for 6.3+ million patients, and reward 5,800+ physicians and advanced practitioners for delivering high-value care.
Privia’s mission is to transform healthcare delivery to achieve better outcomes, lower costs, and improve the health of communities and the well-being of providers. For more information, visit priviahealth.com.
Safe Harbor Statement
Such statements relate to our current expectations, projections and assumptions about our business, the economy and future events or conditions. They do not relate strictly to historical or current facts. Forward-looking statements can be identified by words such as “aims,” “anticipates,” "assumes," “believes,” “estimates,” “expects,” “forecasts,” “future,” “intends,” “likely,” “may,” “outlook,” “plans,” “potential,” “projects,” “seeks,” “strategy,” “targets,” “trends,” “will,” “would,” “could,” “should,” and variations of such terms and similar expressions and references to guidance, although some forward-looking statements may be expressed differently. In particular, these include statements relating to, among other things: our future actions, business plans, objectives and prospects; and our future operating or financial performance and projections, including our full-year guidance for 2026. Factors or events that could cause actual results to differ may emerge from time to time and are difficult to predict. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results may differ materially from past results and those anticipated, estimated or projected. We caution you not to place undue reliance upon any of these forward-looking statements. Management has not reconciled forward-looking non-GAAP measures to their most directly comparable GAAP measures of gross margin, operating income and net income. This is because the Company cannot predict with reasonable certainty and without unreasonable efforts the ultimate outcome of certain GAAP components of such reconciliations due to market-related assumptions that are not within our control as well as certain legal or advisory costs, tax costs or other costs that may arise. For these reasons, management is unable to assess the probable significance of the unavailable information, which could materially impact the amount of the future directly comparable GAAP measures.
Factors related to these risks and uncertainties include, but are not limited to: the heavily regulated industry in which we operate, and any failure by us or our medical groups to comply with the extensive applicable healthcare laws and government regulations; the complexity of the legal framework governing our relationships with Medical Groups, some of which we do not own, and Privia providers, and the impact of legal challenges or shifting interpretations of applicable laws; the execution of our growth strategy, which may not prove viable and we may not realize expected results; difficulties timely implementing our proprietary end-to-end, cloud-based technology solution for Privia physicians and new medical groups; the high level of competition in our industry; challenges in successfully establishing a presence in new geographic markets; the impact of failures by or service disruptions at key third-party vendors, such as our primary electronic medical record vendor, athenahealth, Inc.; potential decreases in reimbursement rates by governmental and third-party payers, changes to payment terms or challenges negotiating and retaining favorable contracts with private third-party payers, and changes impacting our patient population; the financial and operational impact of our compliance with various complex and changing federal and state privacy and security laws and regulations related to our use, disclosure, and other processing of personal information and protected health information, including the Health Insurance Portability and Accountability Act of 1996; the impact of actual and potential security threats, cybersecurity incidents or privacy or other forms of data breaches involving us, our vendors or other third parties; the continued availability of qualified workforce, including staff at our medical groups, and the continued upward pressure on compensation for such workforce; and other risk factors described in our Annual Report on Form 10-K for the year ended December 31, 2025 and the Company’s subsequent Quarterly Reports on Form 10-Q. All information in this press release is as of the date of the release, and the Company undertakes no duty to update this information unless required by law.
Contact:
Robert Borchert
SVP, Investor & Corporate Communications
IR@priviahealth.com
priviapress@priviahealth.com
817.783.4841
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.